最近新增的股票 (30 天)

您沒有最近查詢的記錄。
chg | %

Grape King Bio Ltd  

(�W�����q TPE:1707)   �l�ܦ��Ѳ�  
�j�M��h1707���������G
192.50
+6.00 (3.22%)
4��25�� - ����
TPE ���Y�ɸ�� - �K�d�n��
�d�� 187.00 - 193.50
52 �g 167.00 - 282.00
�}���� 188.00
����q 130.37�U
�`���� 260.29��
���ղv 20.12
�Ѯ�/���q 6.40/2.91
�C�ѬէQ 9.57
�ѥ� 1.34��
�ॴ�t��     -
���c���Ѳv�G     -
2017�~6��16��
Grape King Bio Ltd Annual Shareholders Meeting (Estimated) �s�W�ܦ�ƾ�
  

����έp�ƾڻP��v

2016�~ 12�� 2016�~
�b�Q��v 21.91% 20.54%
��~�Q��v 25.12% 24.32%
��税���«e�Q�� - 26.60%
�����겣�^���v 24.23% 20.78%
�����ѥ��^���v 34.24% 31.30%
���u 485 -
CDP Score - -

�a�}

No. 60, Section 3, Lung-Kang Road
TAOYUAN, 320
Taiwan
+886-3-4572121 (�q��)
+886-3-4572128 (�ǯu)

�����s��

²��

GRAPE KING BIO LTD is a Taiwan-based company principally engaged in the manufacture and sales of healthcare products. The Company mainly provides health foods, such as ganoderma lucidum, cordyceps, as well as lactic acid bacteria products. The Company also produces beverages, pharmaceuticals and cosmetics products, among others. The Company operates through three segments, including Direct Sales segment, Distribution segment and Original Equipment Manufacturer (OEM) segment. The Company operates businesses in Taiwan, Mainland China and other countries.

���Ƨ�

Shenglin Zeng Chairman of the Board, General Manager
Junming Hong Chief Financial Officer
Shengbin Zeng Executive Deputy General Manager, Director
Jinchu Chen Deputy General Manager - Research & Development Division
Meili Chen Director
Yanyi Huang Director
Zheng'an Lai Director
Shengyang Zeng Director
Zhijia Zhang Director